PDAC uses BCKAs secreted by CAFs as substrates for BCAAs synthesis or increases the oxidative metabolic flux of BCKA in a BCKDH-dependent mode
Apperloo EM, Neuen BL, Fletcher RA, et al
( b ) Side view and ( c ) top view of GLP-1R bound to TT-OAD2, PF-06882961, and Ex-4-D-Alas two conformers shown in purple, yellow, blue and orange, respectively
10 Targeting these TAS2Rs with bitter compounds targeting extra-oral bitter taste receptors could be a strategy to influence gastrointestinal motility, and potentially impact hunger signals, similar to the use of pharmaceutical GLP-1 agonists
Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial
Early studies indicated that the peptide might stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat formation) in preclinical settings